Cambrian BioPharma Inc
CIK 1797409 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.69M
Companies
1
Total Filings
58
Lifetime Open-Market Net
$3.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNSE | 10%+ Owner | 130,142 | $13.00 | $1.69M | $3.37M | 58 | 2026-06-01 |
Recent Filings · Page 2 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-21 | SNSE | Buy (P) | +9,500 | $136.2K | EDGAR |
| 2022-04-21 | SNSE | Buy (P) | +752 | $14.9K | EDGAR |
| 2022-03-02 | SNSE | Buy (P) | +1,203 | $3.8K | EDGAR |
| 2022-03-01 | SNSE | Buy (P) | +2,500 | $9.0K | EDGAR |
| 2022-02-28 | SNSE | Buy (P) | +2,500 | $9.1K | EDGAR |
| 2022-02-24 | SNSE | Buy (P) | +17,500 | $64.0K | EDGAR |
| 2022-02-22 | SNSE | Buy (P) | +19,949 | $80.2K | EDGAR |
| 2022-02-16 | SNSE | Buy (P) | +12,551 | $52.6K | EDGAR |
| 2022-02-14 | SNSE | Buy (P) | +17,500 | $77.9K | EDGAR |
| 2022-02-08 | SNSE | Buy (P) | +30,000 | $135.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.